Scandinavian Biopharma and The European Commission’s Health Emergency Preparedness and Response Authority (HERA) has signed a joint procurement framework contract for the supply of diphtheria antitoxin. Eight Member States are participating in the agreement, under which they can purchase 1600 vials of diphtheria antitoxin. Diphtheria is a serious disease and vaccination is the only effective […]
Scandinavian Biopharma Distribution AB has extended and expanded its distribution agreement with Neovii Pharmaceuticals AG. This collaboration involves an extension of the agreement for the immunosuppressive drug Grafalon (anti-human T-lymphocyte immunoglobulin, ATLG) in Sweden, Norway, and Denmark, and now also includes Finland, thus encompassing all the Nordic countries. Grafalon is an antibody-based medication that is […]
Reckitt has appointed Scandinavian Biopharma as the distributor for their Nutramigen products in the Nordic region. These products are classified as Food for Special Medical Purposes (FSMP) and are used by infants and toddlers with cow’s milk protein allergy. “Nutramigen is the latest addition to our innovative product portfolio in child health. We are incredibly […]
Scandinavian Biopharma and Novavax have signed a commercial collaboration agreement for the Covid vaccine Nuvaxovid. Nuvaxovid is an adjuvanted protein-based vaccine that protects against SARS Covid-19. Scandinavian Biopharma has extensive experience in the sale and marketing of vaccines. As of October 2022, the company is the representative for Nuvaxovid on the Swedish market and will […]
We are proud to partner with Bio Products Laboratory (BPL) in recognizing the Hereditary Factor X (10) Deficiency Awareness Day on October 10, 2022. This is a day to encourage education and awareness around a very rare bleeding disorder – Hereditary Factor X Deficiency. About one in a million people have Hereditary Factor X Deficiency, […]
Scandinavian Biopharma has expanded the partnership with Emergent Travel Health Inc. to also include the marketing and distribution of Emergent’s oral typhoid vaccine (Ty21a) in Germany. Emergents oral typhoid vaccine will complement and strengthen Scandinavian Biopharma´s commercial portfolio by leveraging its existing marketing and distribution network in Germany. Due to the travel restrictions during the Covid-19 […]
